William James Alexander
Directeur Technique/Scientifique/R&D chez CORNERSTONE THERAPEUTICS, INC.
Profil
William James Alexander is currently a Senior Director-Medical Affairs at Cornerstone Therapeutics, Inc. and a Member at Infectious Diseases Society of America.
He previously worked as an Independent Director at Soleno Therapeutics, Inc., Vice President-Clinical Development at BioCryst Pharmaceuticals, Inc., Senior Vice President-Product Development at POZEN, Inc., Global Chief Medical Officer at Inveresk Research Group, Inc., President, Chief Executive & Medical Officer at PharmaResearch Corp, and Vice President at Glaxo Wellcome, Inc. He also briefly served as the Chief Operating Officer at Innovation Pharmaceuticals, Inc. Dr. Alexander holds a doctorate from the University of Missouri, an undergraduate degree from Mississippi State University, and a graduate degree from The University of Alabama at Birmingham.
Postes actifs de William James Alexander
| Sociétés | Poste | Début |
|---|---|---|
| CORNERSTONE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | 01/01/2010 |
Anciens postes connus de William James Alexander
| Sociétés | Poste | Fin |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/03/2016 |
| INNOVATION PHARMACEUTICALS INC. | Directeur des opérations | 03/08/2015 |
PharmaResearch Corp
 PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million. | President | 01/01/2003 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | 01/01/1998 |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Directeur Technique/Scientifique/R&D | - |
Formation de William James Alexander
| University of Missouri | Doctorate Degree |
| Mississippi State University | Undergraduate Degree |
| The University of Alabama at Birmingham | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| INNOVATION PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
PharmaResearch Corp
PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million. | Commercial Services |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
| Glaxo Wellcome, Inc. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |